Tampulay, Eliada C.
HRN: 09-91-84 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/22/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/22/2024
07/29/2024
IV
2.25
Q8h
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes